Checkpoint Therapeutics DSO Ratio 2011-2026 | CKPT

Annual DSO Ratio Checkpoint Therapeutics

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	6.83	5.56	159	70	117	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
159	5.56	71.7

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Amneal Pharmaceuticals AMRX	55.7	$ 12.32	-	$ 3.86 B	USA
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Arcutis Biotherapeutics ARQT	106	$ 23.27	-	$ 2.96 B	USA
Autolus Therapeutics plc AUTL	58.2	$ 1.36	-	$ 362 M	Britain
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
Alterity Therapeutics Limited ATHE	16.2 K	$ 3.76	-	$ 9.05 B	Australia
CymaBay Therapeutics CBAY	182	-	-	$ 3.45 B	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Can-Fite BioPharma Ltd. CANF	28.1	$ 3.03	-	$ 6.59 B	Israel
Aytu BioScience AYTU	150	$ 2.57	-3.38 %	$ 16.1 M	USA
Avid Bioservices CDMO	45.6	-	-	$ 789 M	USA
Cidara Therapeutics CDTX	2.26 K	-	-	$ 1.41 B	USA
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
Concert Pharmaceuticals CNCE	147	-	-	$ 401 M	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
CTI BioPharma Corp. CTIC	52.1	-	-	$ 1.2 B	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Cyclacel Pharmaceuticals CYCCP	3.66 K	-	-4.36 %	$ 27 M	USA
Deciphera Pharmaceuticals DCPH	60.8	-	-	$ 2.18 B	USA
Dynavax Technologies Corporation DVAX	56.5	-	-	$ 2.02 B	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Corbus Pharmaceuticals Holdings CRBP	239	$ 9.71	-	$ 129 M	USA
Curis CRIS	103	$ 0.55	0.09 %	$ 7.24 M	USA
Coherus BioSciences CHRS	559	$ 1.67	-	$ 196 M	USA